Omada Health, Inc. (OMDA)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

3 annual periodsNewest to oldest
202520242023
Revenue$260.2M$169.8M$122.8M
Gross profit$170.9M$102.9M$70.0M
Research & development$40.7M$35.9M$33.7M
Operating expenses$182.9M$146.5M$136.0M
Operating income−$12.0M−$43.7M−$66.0M
EBITDAderived−$6.5M−$38.9M−$61.5M
Net income−$12.8M−$47.1M−$67.5M
Basic EPSper diluted share-$0.35-$6.11-$9.52
Diluted EPSper diluted share-$0.35-$6.11-$9.52

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)28$7.23M disclosed value
28 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 29, 2026Form 4 · 10b5-1Gracey CraigChief Accounting OfficerSellCommon Stock2.1K$21.00$43.7K858
Jun 29, 2026Form 4 · 10b5-1Cook Steven L.Chief Financial OfficerSellCommon Stock17.9K$21.07$378.2K115.4K
Jun 26, 2026Form 4 · 10b5-1Gracey CraigChief Accounting OfficerSellCommon Stock2.1K$20.00$41.7K2.9K
Jun 26, 2026Form 4 · 10b5-1Cook Steven L.Chief Financial OfficerSellCommon Stock33.0K$19.89$656.4K133.4K
Jun 26, 2026Form 4 · 10b5-1Duffy Sean P.Chief Executive OfficerSellCommon Stock4.3K$20.90$90.2K394.6K